The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M. Javle, N. J. Curtin

Open source

DOI
10.1177/1758834011417039
Published
2011-08-15
Container
Therapeutic Advances in Medical Oncology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1758834011417039,
  title = {The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy},
  author = {M. Javle and N. J. Curtin},
  year = {2011},
  journal = {Therapeutic Advances in Medical Oncology},
  doi = {10.1177/1758834011417039},
  url = {https://doi.org/10.1177/1758834011417039}
}

RIS

TY  - JOUR
TI  - The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
AU  - M. Javle
AU  - N. J. Curtin
PY  - 2011
JO  - Therapeutic Advances in Medical Oncology
DO  - 10.1177/1758834011417039
UR  - https://doi.org/10.1177/1758834011417039
ER  - 

APA

Javle, M., & Curtin, N. J. (2011). The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/1758834011417039

Source records